US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Gemina Laboratories Ltd (CSE:GLAB)

0.0300 UNCHANGED
Last Price Updated: 9:30 AM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gemina Laboratories Ltd

< Previous 1 2 Next >
News headline image
Gemina Laboratories Announces Private Placement
Via ACCESSWIRE
News headline image
Gemina Laboratories Strategic Update
Via ACCESSWIRE
News headline image
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
Via ACCESSWIRE
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Gemina Labs Announces Addition to its IP Portfolio
Via ACCESSWIRE
News headline image
Gemina Labs to Present at the Life Science Investor Forum June 20th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Gemina Laboratories Sign First Strategic License Agreement
Via ACCESSWIRE
News headline image
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
Via ACCESSWIRE
News headline image
Gemina Announces Closing of $910,000 Convertible Note Financing
Via ACCESSWIRE
News headline image
Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
Via ACCESSWIRE
News headline image
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
Via ACCESSWIRE
ReadyGo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples
Via Get News
News headline image
Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
Via ACCESSWIRE
News headline image
Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
Via ACCESSWIRE
News headline image
Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
Via ACCESSWIRE
News headline image
Gemina Laboratories to Host Investor Webinar on March 30, 2023
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
Via ACCESSWIRE
News headline image
Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy
Via ACCESSWIRE
News headline image
Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
Via ACCESSWIRE
News headline image
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
Via ACCESSWIRE
News headline image
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
Via ACCESSWIRE
News headline image
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
Via ACCESSWIRE
News headline image
Gemina Labs Enters into Licence and Manufacturing Agreements
Via ACCESSWIRE
News headline image
Gemina Labs Presents at the H.C. Wainwright Global Investment Conference
Via ACCESSWIRE
News headline image
Gemina Labs Appoints Diagnostic Executive Brian Firth as Chief Executive Officer
Via ACCESSWIRE
News headline image
Gemina Labs Announces Closing Of Concurrent Private Placement
VANCOUVER, BC / ACCESSWIRE / July 11, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced non-brokered private... 
From Gemina Laboratories Ltd.
Via AccessWire
News headline image
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has closed its previously announced... 
From Gemina Laboratories Ltd.
Via AccessWire
< Previous 1 2 Next >